Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...

California biotech company Cellipont has opened a new 76,000 square foot cell therapy headquarters in The Woodlands' booming ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...

The field of biotechnology has always transformed cutting-edge science into life-changing medicines, but today that transformation is happening at a staggering pace.

IO Biotech (IOBT) announced new pre-clinical data for IO Biotech’s next vaccine candidate, IO112, and additional candidate, IO170, will be ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Cencora, a pharmaceutical and biotechnology company based in Pennsylvania, is expanding in Dothan with an $80 million ...

In the study, published in Science Translational Medicine on Nov. 5, researchers identified proteins expressed on the surface ...

Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...